New therapeutic options for multiple sclerosis in sight

Strategies for treating multiple sclerosis have so far focused primarily on T and B cells. A group of MDC researchers has now unveiled a new approach in Nature Immunology -- one that seeks to increase treatment effectiveness by selectively targeting another type of immune cell called monocytes.